Hepatitis C Antibodies
"Hepatitis C Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.
Descriptor ID |
D018937
|
MeSH Number(s) |
D12.776.124.486.485.114.254.450.510 D12.776.124.790.651.114.254.450.510 D12.776.377.715.548.114.254.450.510
|
Concept/Terms |
Hepatitis C Antibodies- Hepatitis C Antibodies
- Hepatitis C Virus Antibodies
- HCV Antibodies
- Anti-HCV Antibodies
- Anti HCV Antibodies
- Anti-Hepatitis C Virus Antibodies
- Anti Hepatitis C Virus Antibodies
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis C Antibodies".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis C Antibodies".
This graph shows the total number of publications written about "Hepatitis C Antibodies" by people in this website by year, and whether "Hepatitis C Antibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 | 2004 | 1 | 0 | 1 | 2006 | 0 | 1 | 1 | 2011 | 2 | 0 | 2 | 2012 | 1 | 0 | 1 | 2014 | 0 | 1 | 1 | 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis C Antibodies" by people in Profiles.
-
Nordstrom EM, Keniston A, Baouchi F, Martinez-Camacho A. Interferon-based hepatitis C therapy in a safety net hospital: access, efficacy, and safety. Eur J Gastroenterol Hepatol. 2017 Jan; 29(1):10-16.
-
Cachay ER, Hill L, Wyles D, Colwell B, Ballard C, Torriani F, Mathews WC. The hepatitis C cascade of care among HIV infected patients: a call to address ongoing barriers to care. PLoS One. 2014; 9(7):e102883.
-
Lai JC, O'Leary JG, Trotter JF, Verna EC, Brown RS, Stravitz RT, Duman JD, Forman LM, Terrault NA. Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: a multicenter cohort study. Liver Transpl. 2012 May; 18(5):532-8.
-
Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, Jenness SM, Melville SK, Burt R, Thiede H, Al-Tayyib A, Pannala PR, Miles IW, Oster AM, Smith A, Finlayson T, Bowles KE, Dinenno EA. Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites. Clin Infect Dis. 2011 Oct; 53(8):780-6.
-
Bharti AR, Letendre SL, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, Simpson D, Ellis RJ, Grant I. Clinical variables identify seronegative HCV co-infection in HIV-infected individuals. J Clin Virol. 2011 Dec; 52(4):328-32.
-
Ember SW, Schulze H, Ross AJ, Luby J, Khondoker M, Giraud G, Terry JG, Ciani I, Tlili C, Crain J, Walton AJ, Mount AR, Ghazal P, Bachmann TT, Campbell CJ. Fast DNA and protein microarray tests for the diagnosis of hepatitis C virus infection on a single platform. Anal Bioanal Chem. 2011 Nov; 401(8):2549-59.
-
Schnuriger A, Dominguez S, Valantin MA, Tubiana R, Duvivier C, Ghosn J, Simon A, Katlama C, Thibault V. Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals. J Clin Microbiol. 2006 Apr; 44(4):1561-3.
-
Hughes MG, Chong TW, Smith RL, Evans HL, Iezzoni JC, Sawyer RG, Rudy CK, Pruett TL. HCV infection of the transplanted liver: changing CD81 and HVR1 variants immediately after liver transplantation. Am J Transplant. 2005 Oct; 5(10):2504-13.
-
Troesch M, Jalbert E, Canobio S, Boulassel MR, Routy JP, Bernard NF, Bruneau J, Lapointe N, Boucher M, Soudeyns H. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1. AIDS. 2005 May 20; 19(8):775-84.
-
Carlos MP, Yamamura Y, Vu Q, Conzen K, Anderson DE, Torres JV. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b. Clin Immunol. 2004 Apr; 111(1):22-7.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|